Ak. Dhalla et al., ROLE OF OXIDATIVE STRESS IN TRANSITION OF HYPERTROPHY TO HEART-FAILURE, Journal of the American College of Cardiology, 28(2), 1996, pp. 506-514
Objectives. In an attempt to define the role of increased oxidative st
ress in the transition from compensatory hypertrophy to heart failure,
this study examined the effects of long-term vitamin E therapy on the
occurrence of heart failure subsequent to chronic pressure overload i
n guinea pigs. Background. Hyperfunctional heart hypertrophy has been
shown to be accompanied by an increase in the endogenous antioxidant r
eserve, whereas congestive heart failure is accompa nied by a decrease
in this reserve. The effects of vitamin E, a naturally occurring anti
oxidant, on the development of heart failure from a hypertrophic stage
were examined. Methods. The ascending aorta in guinea pigs was coarct
ed. For vitamin treatment, slow-release pellets were implanted at the
time of the operation. The animals were assessed at 10 and 20 weeks fo
r hemodynamic function, myocardial structure, antioxidant agents and o
xidative stress. Results. Banding of the ascending aorta in guinea pig
s resulted in hyperfunctional hypertrophy at 10 weeks, which was follo
wed by congestive heart failure at 20 weeks. Hypertrophied hearts show
ed decreased oxidative stress, as evidenced by a higher oxidation-redu
ction (redox) state and less lipid peroxidation, whereas the failure s
tage was characterized by increased oxidative stress. Supplementation
of animals with timed-release vitamin E tablets resulted in an increas
ed myocardial content of the vitamin, and the banded animals did not d
evelop any signs of heart failure at 20 weeks. Hemodynamic function at
20 weeks in these vitamin E-treated animals was also better maintaine
d. The myocardial reduced glutathione/oxidized glutathione ratio of vi
tamin E-treated animals at 20 weeks was higher and lipid peroxidation
was less compared with the untreated animals. Ultrastructural abnormal
ities were significantly less in the vitamin E-treated hearts compared
with the untreated failing hearts at 20 weeks. Conclusions. An improv
ed myocardial redox state with vitamin E therapy, coupled with the mod
ulation of the development of heart failure, may indicate a pathophysi
ologic role for increased oxidative stress in the pathogenesis of hear
t failure. This study suggests the potential therapeutic value of long
-term antioxidant treatment in modulating or preventing the pathogenes
is of heart failure.